Shares Held (Direct Ownership) 84.8K
0% 3M change
0% 12M change
Total Value Held N/A

BETH C SEIDENBERG Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 18 2023
BUY
Conversion of derivative security
-
84,768 Added 50.0%
84,768 Series A Common Stock

Also insider at

PGNY
Progyny, Inc. Healthcare
VERA
Vera Therapeutics, Inc. Healthcare
ATRA
Atara Biotherapeutics, Inc. Healthcare
SLRN
ACELYRIN, Inc.
KYTX
Kyverna Therapeutics, Inc.
BCS

Beth C Seidenberg

Director
New York, NY

Track Institutional and Insider Activities on SGMT

Follow Sagimet Biosciences Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGMT shares.

Notify only if

Insider Trading

Get notified when an Sagimet Biosciences Inc. insider buys or sells SGMT shares.

Notify only if

News

Receive news related to Sagimet Biosciences Inc.

Track Activities on SGMT